tiprankstipranks
Pulmatrix sees cash runway into 4Q26
PremiumThe FlyPulmatrix sees cash runway into 4Q26
1M ago
Pulmatrix reports Q2 EPS ($1.59) vs. ($1.04) last year
Premium
The Fly
Pulmatrix reports Q2 EPS ($1.59) vs. ($1.04) last year
4M ago
Pulmatrix Announces Executive Changes and New Interim CEO
Premium
Company Announcements
Pulmatrix Announces Executive Changes and New Interim CEO
5M ago
Pulmatrix Publishes Study on Inhalable Migraine Treatment
PremiumCompany AnnouncementsPulmatrix Publishes Study on Inhalable Migraine Treatment
7M ago
Pulmatrix reports Q1 EPS 23c vs ($1.22) last year
Premium
The Fly
Pulmatrix reports Q1 EPS 23c vs ($1.22) last year
8M ago
PULM Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PULM Earnings this Week: How Will it Perform?
9M ago
Pulmatrix submits NDA to FDA to initiate Phase 2 trial of PUR3100
PremiumThe FlyPulmatrix submits NDA to FDA to initiate Phase 2 trial of PUR3100
1y ago
Pulmatrix to present Phase 1 data of PUR3100 in acute migraine
Premium
The Fly
Pulmatrix to present Phase 1 data of PUR3100 in acute migraine
2y ago
Pulmatrix reports Q4 revenue $6.1M vs. $5.2M last year
Premium
The Fly
Pulmatrix reports Q4 revenue $6.1M vs. $5.2M last year
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100